SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: Basildon Bond who wrote (1659)2/12/1999 5:32:00 AM
From: Manfred  Respond to of 2135
 
ENMD: will BMY come back soon?

From today's NY Times:

"A spokesman for Bristol-Myers
Squibb said the company might resume its involvement with angiostatin if
Entremed could develop a reliable manufacturing process and make a
form of angiostatin that proved safe and effective."

Manfred